Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1994 1
1997 1
1999 1
2000 1
2003 1
2004 1
2005 1
2006 3
2008 1
2009 6
2010 4
2011 3
2012 2
2013 1
2014 4
2015 5
2016 4
2017 4
2018 6
2019 4
2020 8
2021 12
2022 8
2023 8
2024 8
2025 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

82 results

Results by year

Filters applied: . Clear all
Page 1
A placebo-controlled trial of oral cladribine for relapsing multiple sclerosis.
Giovannoni G, Comi G, Cook S, Rammohan K, Rieckmann P, Soelberg Sørensen P, Vermersch P, Chang P, Hamlett A, Musch B, Greenberg SJ; CLARITY Study Group. Giovannoni G, et al. N Engl J Med. 2010 Feb 4;362(5):416-26. doi: 10.1056/NEJMoa0902533. Epub 2010 Jan 20. N Engl J Med. 2010. PMID: 20089960 Free article. Clinical Trial.
Long-Term Safety and Efficacy of Eculizumab in Aquaporin-4 IgG-Positive NMOSD.
Wingerchuk DM, Fujihara K, Palace J, Berthele A, Levy M, Kim HJ, Nakashima I, Oreja-Guevara C, Wang KC, Miller L, Shang S, Sabatella G, Yountz M, Pittock SJ; PREVENT Study Group. Wingerchuk DM, et al. Ann Neurol. 2021 Jun;89(6):1088-1098. doi: 10.1002/ana.26049. Epub 2021 Feb 27. Ann Neurol. 2021. PMID: 33586143 Free PMC article. Clinical Trial.
Long-term effectiveness of natalizumab in secondary progressive multiple sclerosis: A propensity-matched study.
Chisari CG, Aguglia U, Amato MP, Bergamaschi R, Bertolotto A, Bonavita S, Morra VB, Cavalla P, Cocco E, Conte A, Cottone S, De Luca G, Di Sapio A, Filippi M, Gallo A, Gasperini C, Granella F, Lus G, Maimone D, Maniscalco GT, Marfia G, Moiola L, Paolicelli D, Pesci I, Ragonese P, Rovaris M, Salemi G, Solaro C, Totaro R, Trojano M, Vianello M, Zaffaroni M, Lepore V, Patti F; Italian MS Register Study Group. Chisari CG, et al. Among authors: morra vb. Neurotherapeutics. 2024 Jul;21(4):e00363. doi: 10.1016/j.neurot.2024.e00363. Epub 2024 May 7. Neurotherapeutics. 2024. PMID: 38714462 Free PMC article.
Cognitive assessment in multiple sclerosis-an Italian consensus.
Amato MP, Morra VB, Falautano M, Ghezzi A, Goretti B, Patti F, Riccardi A, Mattioli F. Amato MP, et al. Among authors: morra vb. Neurol Sci. 2018 Aug;39(8):1317-1324. doi: 10.1007/s10072-018-3427-x. Epub 2018 May 15. Neurol Sci. 2018. PMID: 29766386
ChatGPT vs. neurologists: a cross-sectional study investigating preference, satisfaction ratings and perceived empathy in responses among people living with multiple sclerosis.
Maida E, Moccia M, Palladino R, Borriello G, Affinito G, Clerico M, Repice AM, Di Sapio A, Iodice R, Spiezia AL, Sparaco M, Miele G, Bile F, Scandurra C, Ferraro D, Stromillo ML, Docimo R, De Martino A, Mancinelli L, Abbadessa G, Smolik K, Lorusso L, Leone M, Leveraro E, Lauro F, Trojsi F, Streito LM, Gabriele F, Marinelli F, Ianniello A, De Santis F, Foschi M, De Stefano N, Morra VB, Bisecco A, Coghe G, Cocco E, Romoli M, Corea F, Leocani L, Frau J, Sacco S, Inglese M, Carotenuto A, Lanzillo R, Padovani A, Triassi M, Bonavita S, Lavorgna L; Digital Technologies, Web, Social Media Study Group of the Italian Society of Neurology (SIN). Maida E, et al. Among authors: morra vb. J Neurol. 2024 Jul;271(7):4057-4066. doi: 10.1007/s00415-024-12328-x. Epub 2024 Apr 3. J Neurol. 2024. PMID: 38568227 Free PMC article.
Clinical utility of the Lumipulse™ immunoassay for plasma neurofilament light chain in multiple sclerosis.
Nicolella V, Fiorenza M, Monteiro I, Novarella F, Sirica R, D'Angelo M, Carbone G, La Civita E, Esposito A, Criscuolo V, Carotenuto A, Petracca M, Lanzillo R, Castaldo G, Morra VB, Terracciano D, Moccia M. Nicolella V, et al. Among authors: morra vb. J Neurol Sci. 2024 Aug 15;463:123115. doi: 10.1016/j.jns.2024.123115. Epub 2024 Jun 27. J Neurol Sci. 2024. PMID: 38964268 Free article.
Correction to: Progression independent of relapse activity in relapsing multiple sclerosis: impact and relationship with secondary progression.
Portaccio E, Betti M, De Meo E, Addazio I, Pastò L, Razzolini L, Totaro R, Spitaleri D, Lugaresi A, Cocco E, Onofrj M, Di Palma F, Patti F, Maimone D, Valentino P, Clerici VT, Protti A, Ferraro D, Lus G, Maniscalco GT, Morra VB, Salemi G, Granella F, Pesci I, Bergamaschi R, Aguglia U, Vianello M, Simone M, Lepore V, Iaffaldano P, Comi G, Filippi M, Trojano M, Amato MP; Italian Multiple Sclerosis Register. Portaccio E, et al. Among authors: morra vb. J Neurol. 2024 Oct;271(10):7066-7068. doi: 10.1007/s00415-024-12627-3. J Neurol. 2024. PMID: 39231861 Free PMC article. No abstract available.
SPG5 and multiple sclerosis: clinical and genetic overlap?
Criscuolo C, Carbone R, Lieto M, Peluso S, Guacci A, Filla A, Quarantelli M, Lanzillo R, Morra VB, De Michele G. Criscuolo C, et al. Among authors: morra vb. Acta Neurol Scand. 2016 Jun;133(6):410-4. doi: 10.1111/ane.12476. Epub 2015 Sep 15. Acta Neurol Scand. 2016. PMID: 26370385
82 results